In SEC Filing Ackman Says Allergan is "Sandbagging"

HFA Padded
Mark Melin
Published on
Updated on

William Ackman’s Pershing Square recently filed a Securities and Exchange Commission 14A form regarding statements he made about Allergan, Inc. (NYSE:AGN) in his recent investor letter. Ackman praises his buddy Bill Johnson for working with a cancer research firm The SEC’s 14A form is typically used to provide shareholders information to make “informed” votes at shareholder meetings.  Ackman starts this 14A, which in the title says the filing is related to Allergan, Inc. (NYSE:AGN), by taking about his old Ivy League chum, Bill Doyle, who he recruited to join Ackman at Pershing Square. Ackman makes a plug for the good…

This content is exclusively for paying members of Hedge Fund Alpha

Log In

Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha

Don’t have an account?

Subscribe now and get 7 days free!

HFA Padded

Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.

Comments are closed.